ArticleOncology letters2025

Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases.

Wenzhi Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.